Please assess the completion status of the following clinical trial:

Trial Title: A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 7.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have active rheumatoid arthritis~* Subjects must have failed at least 1 disease modifying anti-rheumatic drug (DMARD)~* Subjects must not be currently taking any DMARD other than an antimalarial~Exclusion Criteria:~* Subjects who discontinued any previous TNF inhibitor therapy for either lack of benefit or safety.~* Subjects who previously received adalimumab (Humira®) therapy for any reason.~* Subjects with evidence of blood disorders, chronic infections or untreated tuberculosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None
- 4 (Type: EXPERIMENTAL): None
- 5 (Type: EXPERIMENTAL): None
- 6 (Type: EXPERIMENTAL): None
- 7 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).